3.2. Secondary Study Endpoints of AMD-Life
drusen
DRUSEN
Improvement of the overall lifestyle score at 24 months.Change of levels of blood biomarkers from serum/plasma and finger-prick at 12 and 24 months.Personal feasibility and acceptability of lifestyle change measured by questionnaires at 3, 6, 9, 12, and 24 months.Changes in macular pigment optical density as measured with MPOD at 12 and 24 months.Changes in quantification of features (e.g., drusen) and stage of AMD as measured on multimodal images at 12 and 24 months.